Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other Non-Current Assets (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Other Non-Current Assets for 16 consecutive years, with $5.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets changed N/A year-over-year to $5.2 million, compared with a TTM value of $5.2 million through Sep 2025, changed N/A, and an annual FY2024 reading of $5.8 million, down 12.95% over the prior year.
  • Other Non-Current Assets was $5.2 million for Q3 2025 at Cross Country Healthcare, down from $5.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $27.1 million in Q2 2022 and bottomed at $5.2 million in Q3 2025.
  • Average Other Non-Current Assets over 5 years is $11.8 million, with a median of $7.4 million recorded in 2021.
  • The sharpest move saw Other Non-Current Assets tumbled 59.0% in 2021, then skyrocketed 37.42% in 2022.
  • Year by year, Other Non-Current Assets stood at $8.0 million in 2021, then decreased by 16.45% to $6.6 million in 2022, then grew by 0.36% to $6.7 million in 2023, then decreased by 12.95% to $5.8 million in 2024, then fell by 10.36% to $5.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for CCRN at $5.2 million in Q3 2025, $5.3 million in Q2 2025, and $5.3 million in Q1 2025.